Gilead
Latest News
November is Pulmonary Hypertension (PH) Awareness Month

Pulmonary arterial hypertension (PAH) is a highly debilitating cardiovascular disease characterized by severe constriction of the blood vessels in the lungs which can lead to heart failure.

For more information, please visit the Pulmonary Hypertension Association’s website at www.PHAssociation.org.

Gilead Sciences
Events
Corporate Responsibility

We are committed to improving the communities in which we live and serve. Our commitment extends beyond the products we offer by demonstrating our compassion and dedication to improving the health of individuals around the world.
Learn more

Gilead Careers and Culture

Our greatest asset is our employees – not only their individual skills, expertise and vision, but their inspired personal commitment to our mission of making a difference in the lives of patients suffering from serious unmet medical needs.
Learn more

Gilead Worldwide

Today, we have more than 3,400 employees and operations in North America and several countries throughout Europe and Australia.
Learn more

Products and Clinical Research
built@zoomedia
Website developed by Zoomedia, Communications for the Life Sciences